EUVIMEDEUVIMED entdecken
Open Access

Sarcoidosis in hospitalised patients in Western Australia: A long-term study on prevalence, comorbidity and mortality.

Johannes Nossent iD, Charles Inderjeeth iD

Sarcoidosis vasculitis and diffuse lung diseases · 30.09.2026 · 43 (3) · 18592-18592

DOI: 10.36141/svdld.2026.18592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 30.09.2026. Verfasst von Johannes Nossent und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Group, School of Medicine, University of Western Australia, Perth, Australia. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To determine disease prevalence, comorbidity and mortality for hospitalised patients with sarcoidosis in Western Australia (WA). METHODS: A retrospective statewide cohort study of patients over 15 years of age hospitalised with sarcoidosis between 1980 and 2014. Sarcoidosis was identified based on validated ICD -9CM/ICD10-AM based algorithms with index admission treated as baseline. Period and point prevalence per 100.000 adult population and mortality rate (MR) per 100 person years were estimated with 95% confidence intervals (CI). Kaplan Meyer survival curves and other outcomes were compared with a comparator group of Rheumatoid Arthritis patients with interstitial lung disease (RA-ILD). Median values are given with interquartile range (IQR). RESULTS: We included 276 patients with sarcoidosis (index age 58 yrs IQR 46-69, 51.4 % females, invasive assessment in 68%) for a period prevalence of 21.1 (CI 18.7-23.7) and a 2015-point prevalence of 12.1 (CI 10.6-13.8). No specific risk factors were identified and extrapulmonary manifestations were recorded in 15%. During follow-up (3428-person years; median 11 years, IQR 5-19), patients with sarcoidosis were more likely to develop hypercalcemia (10.9 vs 4. 1%, p

Schlagwörter

sarcoidosisprevalencecomorbiditiesmortalityhypercalcemiaautoimmune rheumatic diseasescancer incidenceheart failurerheumatoid arthritis-associated interstitial lung diseaseprognosis

Autor:innen und Institutionen

  • Rheumatology Group, School of Medicine, University of Western Australia, Perth, Australia.
  • Rheumatology Group, School of Medicine, University of Western Australia, Perth , Australia.

ORCID-Profile: Johannes Nossent, Charles Inderjeeth

Zitieren

APA

Nossent, J., & Inderjeeth, C. (2026). Sarcoidosis in hospitalised patients in Western Australia: A long-term study on prevalence, comorbidity and mortality. Sarcoidosis vasculitis and diffuse lung diseases, 43(3), 18592-18592. https://doi.org/10.36141/svdld.2026.18592

Vancouver

Nossent J, Inderjeeth C. Sarcoidosis in hospitalised patients in Western Australia: A long-term study on prevalence, comorbidity and mortality. Sarcoidosis vasculitis and diffuse lung diseases. 2026;43(3):18592-18592. doi:10.36141/svdld.2026.18592

BibTeX
@article{Nossent2026,
  author = {Nossent, Johannes and Inderjeeth, Charles},
  title = {Sarcoidosis in hospitalised patients in Western Australia: A long-term study on prevalence, comorbidity and mortality},
  journal = {Sarcoidosis vasculitis and diffuse lung diseases},
  year = {2026},
  volume = {43},
  number = {3},
  pages = {18592--18592},
  doi = {10.36141/svdld.2026.18592}
}
Kostenlos starten →